CoChat

Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on nfκb activation in T lymphocytes during aging: evidence for altered IκB-α phosphorylation and degradation

Ponnappan, Usha, Trebilcock, Gina U, Zheng, Ming-Zhong · 1999 · Experimental Gerontology

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.

Abstract

Nuclear Factor kappa B (NFkappaB) is a critical regulator of several genes involved in immune and inflammatory responses. Treatment of T cells with a variety of stimuli, including TNF-alpha, leads to the translocation of the active p65-50 heterodimer to the nucleus, albeit at a lower level in T cells from the elderly. We demonstrate here that pretreatment with PAO results in the inhibition of NFkappaB induction in TNF-alpha treated T cells, suggesting a role for PAO-sensitive phosphatase in the activation of the NFkappaB via this pathway in human T cells. Furthermore, it demonstrates that aging does not influence the sensitivity of this phosphatase. Treatment with DMP prior to treatment with PAO and TNF abolishes the inhibition induced by PAO, in T cells from both young and old donors, alike. Finally, we demonstrate that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is due to its interference with the phosphorylation of IkappaB-alpha and not due to its inhibitory effect on proteasomal degradation. These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, independent of age.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0531-5565(98)00059-x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Cited by

See all 17

Metadata

Authors
Ponnappan, U., Trebilcock, G. U., & Zheng, M.-Z.
Affiliations
John L. McClellan Memorial Veterans Hospital (US)
Corresponding author
Ponnappan, Usha
Venue
Experimental Gerontology
Publisher
Elsevier BV
Published
1999-01
Volume
34
Issue
1
Pages
95-107
ISSN
0531-5565 (ISSN-L)
OpenAlex
W2157032936
Cited by
17
References
22
Citations by year
2016: 1 · 2012: 1
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Experimental Gerontology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (AG-13081, R01AG013081)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
phenylarsine oxide, protein tyrosine phosphatase, NF-κB activation, T cells, aging, IκBα phosphorylation, IκBα degradation, TNF-α, proteasome, immunosenescence, DMP
MeSH terms
NF-KappaB Inhibitor alpha, Adult, Aged, Aged, 80 and over, Aging, Arsenicals, Cysteine Endopeptidases, DNA-Binding Proteins, Enzyme Inhibitors, Humans, Multienzyme Complexes, Phosphorylation, T-Lymphocytes, Tumor Necrosis Factor-alpha, NF-kappa B, Protein Tyrosine Phosphatases, I-kappa B Proteins, Proteasome Endopeptidase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on nfκb activation in T lymphocytes during aging: evidence for altered IκB-α phosphorylation and degradation. https://app.cochat.ai/papers/10.1016/s0531-5565(98)00059-x
The paper
Ponnappan, U., Trebilcock, G. U., & Zheng, M.-Z. (1999). Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on nfκb activation in T lymphocytes during aging: evidence for altered IκB-α phosphorylation and degradation. Experimental Gerontology. https://doi.org/10.1016/s0531-5565(98)00059-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.